The global medical imaging equipment market size is projected to increase from about USD 52.5 Bn in 2026 to around USD 75.5 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 5.3% during the analysis period (2026-2033). Increasing cases of chronic illness, the rising need for early diagnosis, the improvement in technology of medical equipment such as MRIs, CT scans, and ultrasounds, and the establishment of health care facilities in developing countries are among some reasons behind this trend. According to the WHO, in April 2026, over 90% of adults aged 65+ have at least one chronic condition. The share is more than 75% among those aged 35–64, and about 60% among adults aged 18–34.
X-ray systems are expected to hold the leading market share in the global market of medical imaging equipment in 2026, accounting for nearly 32% of the total product demand. The reason behind their dominance lies in their extensive application in diagnostic purposes, emergencies, orthopedics, and cost-effective screenings.
Advancements in digital radiography (DR) and AI-enhanced X-ray systems have further improved image quality, reduced radiation exposure, and increased diagnostic speed, strengthening adoption in hospitals and diagnostic centers.
In July 2025, GE HealthCare launched its advanced digital X-ray system “Definium Pace Select ET” designed to enhance workflow efficiency, automate positioning, and improve imaging quality in high-volume hospital environments.

To learn more about this report, Request Free Sample
Standalone imaging systems are expected to hold the maximum market share of 65% by 2026 due to the extensive usage of stand-alone imaging systems in hospitals to carry out high-quality imaging processes like CT scans and MRI scans.
The Radiological Society of North America (RSNA) continues to emphasize that standalone devices remain the standard when it comes to high-resolution imaging, especially in specialties like oncology, neurology, and cardiology.
In March 2026, Philips launched its next-generation standalone CT imaging system “Rembra CT” at ECR 2026, designed for high-throughput hospital environments and acute care imaging.
Oncology is expected to dominate the applications market segment with a market share of 25% in 2026, fueled by the growing burden of cancer globally and the increasing need for early detection, staging, and management.
According to the World Health Organization (WHO), cancer is responsible for nearly 10 million deaths annually, and global cancer cases are projected to rise significantly over the next few years.
In December 2025, GE HealthCare announced FDA clearance for its AI-powered MIM LesionID Pro software, designed for whole-body tumor burden analysis in PET/CT imaging.
Hospitals are projected to lead the end-user’s category, having a market share of 55% in 2026, owing to factors such as heavy patient traffic, advanced imaging facilities, and expert radiologists.
According to the American College of Radiology (ACR), hospitals perform the majority of advanced imaging procedures in the U.S., including CT, MRI, and PET scans, due to the need for integrated diagnostic and treatment systems.
The increasing incidence of diseases such as cancer, cardiovascular diseases, and neurological disorders has necessitated the invention of advanced imaging technologies around the world. Diagnostic imaging has become an indispensable component of modern healthcare systems, with modalities such as CT, MRI, ultrasound, and nuclear imaging playing a central role.
According to the World Health Organization (WHO), non-communicable diseases contribute to 74% of all deaths globally, with the major causes being heart-related diseases, cancers, and respiratory diseases. There is an increasing number of such illnesses around the world, thus increasing the need for imaging diagnostic tools.
Technological advancements that include AI diagnostic tools, 3D and 4D imaging, PET-CT technology, and even cloud imaging are revolutionizing both accuracy and efficiency in diagnostic procedures. Their growing adoption is driven by improvements in diagnostic accuracy, workflow efficiency, and clinical outcomes.
The Radiological Society of North America (RSNA) states that AI integration in radiology has the potential to increase efficiency by 30-40% when diagnosing abnormalities in CT and MRI scans.
|
Current Event |
Description and its Impact |
|
2025–2026 Expansion of Medicare Reimbursement for Diagnostic Imaging in the U.S. |
|
|
Rising FDA Approvals for AI-Based Imaging Devices (2024–2026) |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Request Free Sample
The North American region is projected to dominate the worldwide medical imaging devices market, acquiring about 48% of the market in 2026. The growth is attributed to superior health care facilities, increased use of artificial intelligence-enabled imaging devices, and substantial investments in hospitals and diagnostics centers in the U.S. and Canada.
The burden of diseases, along with the penetration of diagnostic services, is another major factor contributing to the increased demand for medical imaging in the region. The high prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is a key driver of imaging demand in the region.
In addition, the OECD Health Statistics highlight that North America has one of the highest imaging utilization rates globally, with advanced healthcare systems performing a significantly large number of MRI and CT scans per population compared to other regions.
The Asia-Pacific region will see the highest growth in the global medical imaging equipment market due to the rapid development of the healthcare infrastructure, increased prevalence of diseases, and the growing use of diagnostic imaging devices in China, India, Japan, and South Korea.
The area is witnessing substantial expansion in investment in both private and public health sectors, resulting in the installation of CT scans, MRI machines, ultrasound machines, and digital X-rays.
According to IFPMA statistics and industry data, the Asia Pacific region holds an increasing percentage of the world's health care demand, driven by the region's growing population base and improved access to healthcare in emerging economies.
In January 2025, Philips launched the AI-enabled CT 5300 system at the Asian Oceanian Congress of Radiology (AOCR 2025) in India, designed to improve diagnostic accuracy, workflow efficiency, and patient throughput in high-volume imaging environments.
The medical imaging equipment market in the U.S. is expected to exhibit high growth rates during the forecast period. This is due to increasing cases of chronic diseases, increasing use of imaging devices with artificial intelligence technology, expansion of hospital infrastructure, and favorable reimbursement policies for imaging tests.
Additionally, the U.S. Food and Drug Administration has approved more than 500 medical devices that use AI/ML technologies, a significant portion of which involve imaging technology.
In March 2026, GE HealthCare announced FDA 510(k) clearance for its “View” diagnostic imaging platform, part of the Genesis Radiology Workspace. The system is designed as a zero-footprint viewer to improve radiology workflow efficiency, enable remote access, and enhance diagnostic precision across U.S. hospitals and outpatient imaging centers.
China is anticipated to be one of the fast-growing and prominent markets for medical imaging devices throughout the forecast period. The expansion in China will be due to increased investments in healthcare infrastructure, higher prevalence of chronic diseases, advancements in medical imaging technology, and robust government initiatives toward healthcare reforms.
In addition, China has one of the fastest-growing cancer burdens globally. According to IARC, China contributes significantly to the nearly 20 million annual global cancer cases. Consequently, there exists high demand for oncology imaging technologies like CT, PET/CT, and MRI devices.
Some of the major key players in Medical Imaging Equipment are GE HealthCare, Siemens Healthineers AG, Koninklijke Philips N.V., Allengers, Shimadzu Corporation, Ziehm Imaging GmbH, Turner Imaging Systems, Hologic, Inc., FUJIFILM Corporation, SternMed GmbH, Genoray Co., Ltd., Eurocolumbus srl. , General Electric, Synaptive Medical, ESAOTE SPA, Aspect Imaging Ltd, Shanghai United Imaging Healthcare Co., LTD, Canon Medical Systems, Aurora Healthcare, Hyperfine, Inc., FONAR Corp, Neusoft Corporation, Medonica Co. LTD and Time Medical Holding.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 52.5 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.3% | 2033 Value Projection: | USD 75.5 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
GE HealthCare, Siemens Healthineers AG, Koninklijke Philips N.V., Allengers, Shimadzu Corporation, Ziehm Imaging GmbH, Turner Imaging Systems, Hologic, Inc., FUJIFILM Corporation, SternMed GmbH, Genoray Co., Ltd., Eurocolumbus srl. , General Electric, Synaptive Medical, ESAOTE SPA, Aspect Imaging Ltd, Shanghai United Imaging Healthcare Co., LTD, Canon Medical Systems, Aurora Healthcare, Hyperfine, Inc., FONAR Corp, Neusoft Corporation, Medonica Co. LTD and Time Medical Holding |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients